Cancer is often easier to treat when it is found early. However, one of the biggest challenges doctors face is that many cancers begin with vague symptoms that can be caused by many different conditions.
Feeling tired all the time, losing weight without trying, having unexplained pain, or simply feeling unwell are common reasons people visit their doctor. These symptoms may be linked to cancer, but they can also be caused by infections, autoimmune diseases, stress, or many other health problems.
Because these symptoms are so common and non-specific, it can be difficult for doctors to know which patients need urgent cancer testing and which do not. As a result, some people may go through many tests before receiving a diagnosis, while others may experience delays in getting the care they need.
Now, researchers in Sweden have developed a promising approach that may help doctors identify cancer earlier using a simple blood test. The study was carried out by scientists from institutions including Karolinska Institutet and Danderyd Hospital.
Their findings suggest that proteins circulating in the blood may provide valuable clues about whether a person’s symptoms are caused by cancer.
Proteins are essential molecules that help the body perform countless functions. Different diseases can change the levels of certain proteins in the bloodstream. By studying these changes, scientists hope to find biological signals that reveal what is happening inside the body before obvious signs appear.
To investigate this possibility, the research team collected blood samples from nearly 700 patients who were being evaluated for unexplained symptoms that could potentially be linked to cancer. Importantly, the blood samples were taken before patients underwent major diagnostic procedures such as scans, biopsies, or other advanced tests.
The researchers then used a powerful scientific technique known as proteomics. Proteomics allows scientists to measure large numbers of proteins at the same time and identify patterns associated with specific diseases. In this study, the team examined the levels of 1,463 different proteins in each blood sample.
After analyzing the data, the researchers discovered a distinct pattern of proteins that appeared much more often in people who were later diagnosed with cancer.
This pattern, known as a protein signature, acted like a biological fingerprint. By identifying this signature, the researchers were able to create a model that could distinguish cancer from other illnesses that often cause similar symptoms.
One particularly important aspect of the study was the choice of comparison groups. Rather than comparing cancer patients only with healthy individuals, the researchers included patients who had other serious medical conditions.
These included infections and autoimmune diseases, which can produce symptoms very similar to those seen in cancer patients.
This approach makes the findings more useful in real-world healthcare settings. In everyday medical practice, doctors are rarely trying to distinguish cancer from perfect health. Instead, they are trying to determine whether symptoms are caused by cancer or by another illness.
By testing the model against people with a variety of diseases, the researchers were able to create a more realistic and potentially more accurate diagnostic tool.
The scientists emphasize that the blood test is not intended to replace existing cancer diagnostic methods. Medical imaging, biopsies, and other tests will still be needed to confirm a diagnosis.
However, the blood test could serve as an early screening tool that helps doctors decide which patients should receive those more detailed investigations sooner.
Such a tool could provide several benefits. Patients at higher risk could be prioritized for scans and specialist referrals, potentially leading to earlier diagnosis and treatment. At the same time, patients who are less likely to have cancer might avoid unnecessary tests, reducing stress, costs, and exposure to invasive procedures.
Early cancer detection remains one of the most important goals in modern medicine. Many cancers have much better outcomes when they are found before they spread to other parts of the body. Researchers around the world are searching for new blood-based methods that can detect cancer quickly, accurately, and with minimal discomfort for patients.
Although the results of this study are encouraging, the researchers caution that more work is needed before the test can become part of routine medical care. The current study involved patients who were already being assessed in hospital settings, where the likelihood of serious disease is relatively high.
The next step will be to test the approach in primary care clinics, where most people first seek medical help. In these settings, cancer is much less common, making it a more challenging environment for any screening tool. Researchers want to determine whether the protein signature remains accurate and reliable when used in the broader population.
If future studies confirm these findings, doctors may one day have a powerful new tool to help identify cancer earlier in people with unexplained symptoms. A simple blood test could help guide medical decisions, speed up diagnoses, and improve outcomes for many patients.
The study was conducted by researchers from Karolinska Institutet, Danderyd Hospital, and collaborating institutions in Sweden.
Copyright © 2026 Knowridge Science Report. All rights reserved.
